Publicaciones (90) Publicaciones en las que ha participado algún/a investigador/a

2024

  1. 4-Hydroxybenzoic acid rescues multisystemic disease and perinatal lethality in a mouse model of mitochondrial disease

    Cell Reports, Vol. 43, Núm. 5

  2. Allosteric control of dynamin-related protein 1 through a disordered C-terminal Short Linear Motif

    Nature Communications, Vol. 15, Núm. 1

  3. Changes in Cortisol and in Oxidative/Nitrosative Stress Indicators after ADHD Treatment

    Antioxidants, Vol. 13, Núm. 1

  4. Distribution of intracellular Ca2+-ATPases in the mouse retina and their involvement in light-induced cone degeneration

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1871, Núm. 1

  5. Early heart and skeletal muscle mitochondrial response to a moderate hypobaric hypoxia environment

    Journal of Physiology

  6. Inflamma-miRs Profile in Myelodysplastic Syndrome Patients

    International Journal of Molecular Sciences, Vol. 25, Núm. 12

  7. Machine Learning Model to Classify Patients with Complicated and Uncomplicated Type 2 Diabetes Mellitus in the New Civil Hospital of Guadalajara “Juan I. Menchaca”

    IFMBE Proceedings

  8. Membrane fission via transmembrane contact

    Nature Communications, Vol. 15, Núm. 1

  9. New variants expand the neurological phenotype of COQ7 deficiency

    Journal of Inherited Metabolic Disease

  10. Oral β-RA induces metabolic rewiring leading to the rescue of diet-induced obesity

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 7

  11. The role of mitochondrial bioenergy and system glutathione in deficiency of Coenzyme Q and Complex I

    BIO Web of Conferences

  12. Using Redox Proteomics to Gain New Insights into Neurodegenerative Disease and Protein Modification

    Antioxidants, Vol. 13, Núm. 1

  13. Zebrafish as a Human Muscle Model for Studying Age-Dependent Sarcopenia and Frailty

    International Journal of Molecular Sciences, Vol. 25, Núm. 11

  14. iMS-Bmal1−/− mice show evident signs of sarcopenia that are counteracted by exercise and melatonin therapies

    Journal of Pineal Research, Vol. 76, Núm. 1

2023

  1. A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in surgical patients with severe sepsis admitted to the intensive care unit

    Journal of Pineal Research, Vol. 74, Núm. 2

  2. Chronodisruption and Loss of Melatonin Rhythm, Associated with Alterations in Daily Motor Activity and Mitochondrial Dynamics in Parkinsonian Zebrafish, Are Corrected by Melatonin Treatment

    Antioxidants, Vol. 12, Núm. 4

  3. Comprehensive Pan-cancer Gene Signature Assessment through the Implementation of a Cascade Machine Learning System

    Current Bioinformatics, Vol. 18, Núm. 1, pp. 40-54

  4. From Chronodisruption to Sarcopenia: The Therapeutic Potential of Melatonin

    Biomolecules, Vol. 13, Núm. 12

  5. Identification of PIK3CG as a hub in septic myocardial injury using network pharmacology and weighted gene co-expression network analysis

    Bioengineering and Translational Medicine, Vol. 8, Núm. 1

  6. Insights into the Role of Plasmatic and Exosomal microRNAs in Oxidative Stress-Related Metabolic Diseases

    Antioxidants, Vol. 12, Núm. 6